This brand name is authorized in Hong Kong SAR China, Israel, Netherlands, Poland, Singapore, South Africa, Turkey.
The drug MEGALOTECT contains one active pharmaceutical ingredient (API):
1
|
UNII
129L90A25N - HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN
|
|
Cytomegalovirus immunoglobulin is used as a CMV-specific polyclonal immunoglobulin preparation that binds to CMV surface antigens thereby neutralizing the potential of CMV from entering host cells and presenting the CMV particle for phagocytosis. Furthermore, cytomegalovirus immunoglobulin can activate CMV-reactive immune cells for long-lasting CMV-specific immune responses. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J06BB09 | Cytomegalovirus immunoglobulin | J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BB Specific immunoglobulins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| HK | Department of Health Drug Office | 66874 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 6893 |
| NL | Z-Index G-Standaard, PRK | 134457, 134465 |
| PL | Rejestru Produktów Leczniczych | 100406130 |
| SG | Health Sciences Authority | 14452P |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699535980622, 8699535980639 |
| ZA | Health Products Regulatory Authority | 28/30.2/0110 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.